We recommend that along with the conventionally used biomarkers i.e. ZAP-70 and CD38, CD49d should also be added to the immunophenotyping panel for stratification of prognostic groups in CLL. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.